While EWS/Fli1 expression is inarguably essential to the survival of Ewing sarcoma cells, emerging experimental and clinical evidence suggests that these tumors have significant intra-tumoral transcriptional heterogeneity, characterized by the heterogenous activation of EWS/Fli1 [8]. The gene discussed is EWSR1; the disease is Ewing sarcoma.